Ambuja Cements Q2 FY’26 Revenue Soars, Capacity Expansion Underway
Ambuja Cements reported a strong Q2 FY’26 with revenue at ₹9,174 Cr, up 21% YoY. EBITDA reached ₹1,060/PMT. The company is increasing…
Ajanta Pharma Record Date Set for Interim Dividend
Ajanta Pharma has announced November 10, 2025, as the record date for determining shareholders eligible to receive the company’s first…
Ajanta Pharma PAT Up 20% in Q2 FY26, Interim Dividend Declared
Ajanta Pharma announced a 20% increase in Profit After Tax (PAT) for Q2 FY26. The company’s revenue from operations rose by 14% to…
Ambuja Cements Achieves Robust Q2 FY26 Performance, PAT Up 364%
Ambuja Cements reported a strong Q2 FY26 performance, with PAT at Rs. 2,302 Cr, up 364% YoY. The company achieved its highest ever quarterly…
Ajanta Pharma Q2 FY26 Profit After Tax Up by 20%
Ajanta Pharma announced a 20% increase in Profit After Tax (PAT) for Q2 FY26. The company reported a revenue increase of 14%, reaching ₹1,354…
PCBL Chemical Kaushik Roy Resigns as Managing Director, Nilesh Koul Appointed
PCBL Chemical has announced that Kaushik Roy has resigned as Managing Director, effective November 3, 2025, due to personal reasons. The Board…
Ajanta Pharma Profit After Tax Up 20% in Q2 FY26
Ajanta Pharma reported a 20% increase in Profit After Tax (PAT) for Q2 FY26, reaching ₹260 cr. Revenue from operations grew by 14% to ₹1,354…
Ambuja Cements Reports ₹1,387.55 Crore Profit After Tax for Q2 2025
Ambuja Cements announced its unaudited financial results for Q2 2025, reporting a ₹1,387.55 crore profit after tax. Revenue from operations…
Blue Dart Investor Presentation Highlights Growth Strategy
Blue Dart Express has released an investor presentation highlighting its market leadership, growth strategy, and financial performance. The…
Rashtriya Chemicals Board Meeting to Discuss Q2 Financial Results
The Board of Directors of Rashtriya Chemicals and Fertilizers Limited will convene on November 14, 2025, to review and approve the unaudited…